Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease

References

• Piccolo R, Giustino G, Mehran R, et al. Stable coronary artery disease: revascularisation and invasive strategies. Lancet. 2015;386:702–713.
   PubMed Web of Science ®Google Scholar
• Task Force Members, Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949–3003
   PubMed Web of Science ®Google Scholar
• Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440–1445.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045–2051.
   PubMed Web of Science ®Google Scholar
• Moreira DM, da Silva RL, Vieira JL, et al. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Am J Cardiovasc Drugs. 2015;15:1–11.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Grove EL, Wurtz M, et al. The influence of low-grade inflammation on platelets in patients with stable coronary artery disease. Thromb Haemost. 2015;114:519–529.
   PubMed Web of Science ®Google Scholar
• Kaptoge S, Seshasai SR, Gao P, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35:578–589.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Jablonski KA, PEACE Investigators, et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115:1528–1536.
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–1397.
   PubMed Web of Science ®Google Scholar
• Fisman EZ, Benderly M, Esper RJ, et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol. 2006;98:14–18.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Grove EL, Pareek M, et al. Calprotectin and platelet aggregation in patients with stable coronary artery disease. PLoS One. 2015;5:e0125992.
   Google Scholar
• Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;269:10425–10432.
   Google Scholar
• Kjeldsen L, Bainton DF, Sengelov H, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83:799–807.
   PubMed Web of Science ®Google Scholar
• Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276:37258–37265.
   PubMed Web of Science ®Google Scholar
• Sahinarslan A, Kocaman SA, Bas D, et al. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coron Artery Dis. 2011;22:333–338.
   PubMed Web of Science ®Google Scholar
• S, Pedersen SH, Mogelvang R, et al. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2012;60:339–345.
   PubMed Web of Science ®Google Scholar
• Kafkas N, Demponeras C, Zoubouloglou F, et al. Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease. Int J Inflam. 2012;2012:1.
   Google Scholar
• Zografos T, Haliassos A, Korovesis S, et al. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol. 2009;104:917–920.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Grove EL, Neergaard-Petersen S, et al. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease. PLoS One. 2015;5:e0126767.
   Google Scholar
• Schmidt M, Maeng M, Jakobsen CJ, et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol. 2010;2:137–144.
   PubMedGoogle Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–549.
   PubMed Web of Science ®Google Scholar
• , Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Nat Rev Cardiol. 2012;9:620–695.
   PubMed Web of Science ®Google Scholar
• Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999;46:354–357.
   PubMed Web of Science ®Google Scholar
• Wildenschild C, Mehnert F, Thomsen RW, et al. Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients. Clin Epidemiol. 2013;6:27–36.
   PubMed Web of Science ®Google Scholar
• Cheng JM, Akkerhuis KM, Meilhac O, et al. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography. Arterioscler Thromb Vasc Biol. 2014;34:1078–1084.
   PubMed Web of Science ®Google Scholar
• Soylu K, Aksan G, Nar G, et al. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome. Anatol J Cardiol. 2015;15:450–455.
   PubMed Web of Science ®Google Scholar
• Sarndahl E, Bergstrom I, Brodin VP, et al. Neutrophil activation status in stable coronary artery disease. PLoS One. 2007;2:e1056.
   PubMed Web of Science ®Google Scholar
• Paulsson J, Dadfar E, Held C, et al. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis. 2007;192:328–334.
   PubMed Web of Science ®Google Scholar
• Katagiri M, Takahashi M, Doi K, et al. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease. Heart Vessels. 2015;31:1595–1602.
   PubMed Web of Science ®Google Scholar
• Woitas RP, Scharnagl H, Kleber ME, et al. Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-impact for mortality. PLoS One. 2017;2:e0171574.
   Google Scholar
• Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M, et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis. 2012;220:552–556.
   PubMed Web of Science ®Google Scholar
• Fassett RG, Robertson IK, Ball MJ, et al. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial. Nephrol Dial Transplant. 2012;27:182–189.
   PubMed Web of Science ®Google Scholar
• Eilenberg W, Stojkovic S, Piechota-Polanczyk A, et al. Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment. Cardiovasc Diabetol. 2017;16.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Grove EL, Kristensen SD, et al. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. Thromb Haemost. 2013;5:920–929.
   Web of Science ®Google Scholar